Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

GSK plc DRC (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GSK plc DRC's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.76 -0.19    -0.46%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
40.70
-0.06
-0.15%
19:41:59 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,538,127
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 40.68 - 41.02
GSK plc DRC 40.76 -0.19 -0.46%

GSK User Rankings

 
Users ranking according to the performance of their sentiments for the GSK plc DRC stock.
RankUsernameTotalClosedWinningWin %Chg. %
1David Bundy111100+17.83%
2Jagdish Patel111100+15.62%
3Alice Cook111100+15.59%
4Roman Pyndyk111100+13.79%
5LuckyTrader111100+13.76%
6Gabriel Sabino222100+13.4%
7Zer0W0n111100+13.23%
8Ronald Favis111100+12.68%
9Eleni Boura111100+12.68%
10loke wai hoong111100+12.5%
11Lucas Cairella111100+10.6%
12Solomon222100+10.51%
13Oliver Leemon111100+8.36%
14יעקב המלי111100+7.11%
15ziya yılmaz99777.78+5.96%
16Alfa Luso111100+5.91%
17Stefan Geyer111100+5.56%
18Анатолий Анатолий111100+5.25%
19Miguel Eloi222100+4.94%
20Fl Fa111100+4.85%
21Mohammad Alhamad111100+4.63%
22James Benton111100+4.16%
23Logan Rezvani111100+3.87%
24ming yi111100+3.22%
25Joao Passadiço111100+3.17%
26yura bondarev111100+3.13%
27中山 一也111100+2.75%
28miso er111100+2.59%
29Andy Fillo1000+2.27%
30Kürşat Özer111100+2%
31Davide Fantoni111100+1.69%
32Bob Crawford111100+1.51%
33Dmytro Berbasov111100+1.22%
34jm landaluce111100+0.9%
35Ricky Carter111100+0.87%
36Enrique Lucas111100+0.78%
37Sezer Binici111100+0.45%
38Anita Vacca111100+0.43%
39James Brewer11000%
40Chris Klaver1100-0.07%
41Marianela Perez1100-0.15%
42Ivica Maurovic1100-0.39%
43Анна Аносова1100-0.72%
44David Havrlant1100-0.79%
45上原 翔太1100-1.39%
46Yu Tanahashi1100-1.88%
47Mark Nickerson1100-1.89%
48Jimmy Yiu1100-2.2%
49덕수 김1100-2.21%
50Ulash Ozturk1100-2.55%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
William Hineser
William Hineser Feb 28, 2024 2:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Most large international pharm companies are good long term investments.
William Hineser
William Hineser Feb 05, 2024 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally, some improvement, with reservations.
William Hineser
William Hineser Nov 14, 2023 10:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
One of the few pharm companies not improving. Why?
Arth Dlg
Arth Dlg Apr 27, 2023 9:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RSV approval is a great announcement. I am buying :)
Jeff Chui
Jeff Chui Sep 15, 2022 9:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy here 31.2 Someone just bought 700k shares ($21million) pre market
daniel daniel
daniel daniel Sep 15, 2022 9:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes i entered at the same price, went against my rule of waiting the SPY to fall to the support level which would be around 365, i hope it was not a trick to get some new hodlers .... yet i feel relaxed because of the high dividend
peter pan
peter pan Aug 18, 2022 7:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK will fall to $25 level. Mark my words.
Jay Ow
Jay Ow Aug 18, 2022 7:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They all can do whatever after covid fraud. I do not want see any of these MED stocks at all for me and for many others they are just Murderers
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought @ 34.36
Jaeyong Lee
Jaeyong Lee Aug 17, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought @33.07
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i bought for long term , now the stimulus in Europe will pump this stock.
Patricio Garnica
Patricio Garnica Aug 11, 2022 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is It a good entry point?
Mo Ali
Av8er31 Aug 11, 2022 1:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Absolutely.
William Hineser
William Hineser Aug 11, 2022 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Glad I don't have many shares.
True Thao
True Thao Aug 11, 2022 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🤣🤣🤣
Jonathan Sanders
Jonathan Sanders Aug 03, 2022 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GSK recently struck a deal to purchase Sierra Oncology (SRRA) for a total of $1.9 billion to bolster its oncology offerings.... what we think about this acquisition
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email